Collaborate with us in advancing bold science that can impact patients lives
January 2025
At MSD we are not afraid to make bold investments in external science where we believe we can further our mission to save and improve lives.
Consider partnering with us…
We know that collaborations are critical to advancing bold science. Our robust pipeline and portfolio are fuelled by both our own discoveries and external innovation. We leverage our company’s strengths, including our global capabilities from discovery research through commercialisation, to work with our partners to bring new and life-changing therapies to patients.
Our Business Development and Licensing (BD&L) team are focused on identifying breakthrough science and collaborating together to make the greatest difference for patients, now and in the future.
Where are we located?
We’re open to collaboration anywhere the science leads us. Our team of business development and licensing colleagues are co-located within our research & development sites in Boston, South San Francisco and London — epicentres of scientific innovation.
We are searching the world for cutting-edge science regardless of therapeutic area or modality. To find out more about our areas of focus, recent acquisitions and collaborations read more on our global website here or get in touch via the collaborate link.
We share your urgency to transform health care for patients and will act decisively when there’s an opportunity to make a meaningful impact on patients’ lives.
GB-NON-10791 | January 2025